1.03
+0.01(+0.98%)
Currency In USD
| Previous Close | 1.02 |
| Open | 1.01 |
| Day High | 1.05 |
| Day Low | 0.98 |
| 52-Week High | 3.95 |
| 52-Week Low | 0.69 |
| Volume | 337,143 |
| Average Volume | 1.88M |
| Market Cap | 49.34M |
| PE | -0.85 |
| EPS | -1.21 |
| Moving Average 50 Days | 0.88 |
| Moving Average 200 Days | 1.07 |
| Change | 0.01 |
If you invested $1000 in Shattuck Labs, Inc. (STTK) since IPO date, it would be worth $53.23 as of August 20, 2025 at a share price of $1.03. Whereas If you bought $1000 worth of Shattuck Labs, Inc. (STTK) shares 3 years ago, it would be worth $330.13 as of August 20, 2025 at a share price of $1.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
GlobeNewswire Inc.
Aug 05, 2025 10:30 AM GMT
– Aggregate net proceeds expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease – – Pro forma cash and cash equivalents from aggregate proceeds antici
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
GlobeNewswire Inc.
Jul 02, 2025 11:00 AM GMT
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 02, 2025 9:00 PM GMT
AUSTIN, TX and DURHAM, NC, April 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for th